Literature DB >> 1691241

Anti-Mycobacterium leprae monoclonal antibodies cross-react with human skin: an alternative explanation for the immune responses in leprosy.

B Naafs1, A H Kolk, R A Chin A Lien, W R Faber, G Van Dijk, S Kuijper, E Stolz, T Van Joost.   

Abstract

A panel of 17 mouse monoclonal antibodies (MoAb) raised against Mycobacterium leprae (M. leprae) antigens was used to detect antigenic determinants in normal human skin. An indirect immunoperoxidase technique was used. Eight of the MoAb detected epidermal antigens similar to patterns well known for human sera. Five of these MoAb detected determinants in the dermis, too. These observations may indicate a certain degree of similarity between the antigenic determinants occurring in M. leprae and in the human host. We propose that such a similarity on the one hand may facilitate the survival of M. leprae in the human host when the antigens are not recognized as "non-self," a situation which seems to occur in lepromatous leprosy, when the patients' tissues are loaded with bacteria virtually without any immune response. On the other hand, M. leprae antigens which mimic host antigens may induce an auto-immune reaction against the host's own antigens, which could explain the immune reaction in tuberculoid leprosy and during a "reversal reaction" when M. leprae is not observed in the host tissues, but extensive granuloma formation occurs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1691241     DOI: 10.1111/1523-1747.ep12876264

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

1.  Immunohistological analysis of in situ expression of mycobacterial antigens in skin lesions of leprosy patients across the histopathological spectrum. Association of Mycobacterial lipoarabinomannan (LAM) and Mycobacterium leprae phenolic glycolipid-I (PGL-I) with leprosy reactions.

Authors:  C Verhagen; W Faber; P Klatser; A Buffing; B Naafs; P Das
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

2.  The mycobacterial secreted antigen 85 complex possesses epitopes that are differentially expressed in human leprosy lesions and Mycobacterium leprae-infected armadillo tissues.

Authors:  A Rambukkana; J D Burggraaf; W R Faber; M Harboe; P Teeling; S Krieg; P K Das
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

3.  Mycobacterial 65,000 MW heat-shock protein shares a carboxy-terminal epitope with human epidermal cytokeratin 1/2.

Authors:  A Rambukkana; P K Das; S Krieg; S Young; I C Le Poole; J D Bos
Journal:  Immunology       Date:  1992-10       Impact factor: 7.397

4.  Mycobacteria and human autoimmune disease: direct evidence of cross-reactivity between human lactoferrin and the 65-kilodalton protein of tubercle and leprosy bacilli.

Authors:  N Esaguy; A P Aguas; J D van Embden; M T Silva
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

5.  Immunohistological localization of mycobacterial antigens within the peripheral nerves of treated leprosy patients and their significance to nerve damage in leprosy.

Authors:  V P Shetty; M W Uplekar; N H Antia
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

6.  Autoimmunity to Tropomyosin-Specific Peptides Induced by Mycobacterium leprae in Leprosy Patients: Identification of Mimicking Proteins.

Authors:  Itu Singh; Asha Ram Yadav; Keshar Kunja Mohanty; Kiran Katoch; Prashant Sharma; Vinay Kumar Pathak; Deepa Bisht; Umesh D Gupta; Utpal Sengupta
Journal:  Front Immunol       Date:  2018-04-03       Impact factor: 7.561

7.  Leprosy: a review of laboratory and therapeutic aspects--part 2.

Authors:  Joel Carlos Lastória; Marilda Aparecida Milanez Morgado de Abreu
Journal:  An Bras Dermatol       Date:  2014 May-Jun       Impact factor: 1.896

8.  Mimicking B and T cell epitopes between Mycobacterium leprae and host as predictive biomarkers in type 1 reaction in leprosy.

Authors:  Vinay Kumar Pathak; Itu Singh; Shoor Vir Singh; Utpal Sengupta
Journal:  Sci Rep       Date:  2021-12-24       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.